Search results for "TREATMENT"

showing 10 items of 17623 documents

Personality characteristics related to interpersonal relations and self-perception measured by Rorschach (CS) and self-reported interpersonal problem…

1998

self-perceptioncoping-styleRorschach (CS)Inventory of Interpersonal Problems (IIP)control capacitypretreatment assesmentinterpersonal relations
researchProduct

Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double-blinded randomized study between…

2014

serenoa repensMaleProstatic HyperplasiaAntioxidantsSettore MED/24 - UrologiaSeleniumDouble-Blind MethodDrug TherapyLower Urinary Tract SymptomsSerenoa80 and overHumansBPH; LUTS; lycopene; phytotherapy; selenium; serenoa repens; tamsulosin; Aged; Aged 80 and over; Antioxidants; Carotenoids; Double-Blind Method; Drug Therapy Combination; Humans; Italy; Lower Urinary Tract Symptoms; Male; Middle Aged; Phytotherapy; Prostatic Hyperplasia; Quality of Life; Selenium; Serenoa; Sulfonamides; Treatment Outcome; Urodynamics; Urological AgentsAgedSulfonamidesLUTSphytotherapyMiddle AgedlycopeneCarotenoidsBPH LUTS lycopene phytotherapy selenium serenoa repens tamsulosinUrodynamicsTreatment OutcomeItalyBPHtamsulosinCombinationQuality of LifeUrological Agentsserenoa repens; lycopene; selenium; tamsulosin; LUTS; BPH; phytotherapy
researchProduct

Real-world experience with dupilumab in severe asthma: One-year data from an italian named patient program

2021

Raffaele Campisi,1 Claudia Crimi,1 Santi Nolasco,2 Bianca Beghè,3 Leonardo Antonicelli,4 Gabriella Guarnieri,5 Nicola Scichilone,6 Morena Porto,2 Luigi Macchia,7 Giulia Scioscia,8 Maria Pia Foschino Barbaro,8 Alberto Papi,9 Nunzio Crimi1,2 1Respiratory Medicine Unit, A.O.U. Policlinico “G. Rodolico -San Marco”, Catania, Italy; 2Department of Clinical and Experimental Medicine, Section of Respiratory Diseases, University of Catania, Catania, Italy; 3Respiratory Medicine Unit, Department of Medicine, University of Modena and Reggio Emilia, Modena, Italy; 4Allergy Unit, Department of Internal Medicine, Ancona University Hospital, Ancona, Italy; 5Department of Car…

severe asthmaPulmonary and Respiratory MedicineSevere asthmareal-worldmedicine.medical_specialtyTreatment responseSevere asthmaSocio-culturaleDupilumab Named Patient Program Oral corticosteroids Real-world Severe asthmaHypereosinophiliaDupilumaboral corticosteroidsSettore MED/10 - Malattie Dell'Apparato Respiratoriolaw.inventionNamed Patient Program dupilumab oral corticosteroids real-world severe asthma03 medical and health sciences0302 clinical medicineRandomized controlled triallawdupilumabInternal medicineOral corticosteroidsJournal of Asthma and AllergymedicineImmunology and Allergy0601 history and archaeologyOriginal Research060102 archaeologybusiness.industryRetrospective cohort study06 humanities and the artsRC581-607Named Patient ProgramEosinophilDupilumabmedicine.anatomical_structureReal-world030228 respiratory systemCohortImmunologic diseases. Allergymedicine.symptombusinessDupilumab; Named Patient Program; Oral corticosteroids; Real-world; Severe asthma
researchProduct

Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthma

2021

BACKGROUND: Various studies have assessed omalizumab outcomes in the clinical practice setting but follow-up and/or number of patients included were limited. We aim to describe the long-term outcomes of pediatric patients with severe persistent allergic asthma receiving omalizumab in the largest real-life cohort reported to date. METHODS: ANCHORS was a multicenter, observational, retrospective cohort study conducted in 25 Pediatric Allergy and Pulmonology units in Spain. We collected data of patients < 18 years and initiating omalizumab between 2006 and 2018, from the year prior to omalizumab initiation to discontinuation or last available follow-up. The primary outcome was the evolution of…

severe asthmamedicine.medical_specialtyPediatricsImmunology*real lifeOmalizumabhumanized monoclonal antibodiesOmalizumab*adolescentsAntibodies Monoclonal HumanizedAnti-asthmatic Agent03 medical and health sciences0302 clinical medicinechildrenreal lifeInternal medicinemedicine*anti-asthmatic agents*childrenHumansImmunology and AllergyChildren adolescents anti-asthmatic agents humanized monoclonal antibodies observational study omalizumab real-life severe asthmaAnti-Asthmatic Agentsadolescents030212 general & internal medicineChildAdverse effectRetrospective Studiesbusiness.industryasthmatic agents*observational studyanti&#8208Retrospective cohort studyAsthmaDiscontinuation*omalizumabTreatment OutcomePulmonology030228 respiratory system*humanized monoclonal antibodies*severe asthmaSevere persistent allergic asthmaPediatrics Perinatology and Child HealthCohortomalizumabobservational studyObservational studybusinessmedicine.drugPediatric Allergy and Immunology
researchProduct

Editorial: Sex differences in cerebrovascular diseases

2023

sex differencespreventiontreatmentNeurologyoutcomeoutcome; prevention; sex differences; stroke; treatmentNeurology (clinical)strokeFrontiers in Neurology
researchProduct

Monitoring WWTP performance using size-exclusion chromatography with simultaneous UV and fluorescence detection to track recalcitrant wastewater frac…

2018

A trial monitoring of a typical full-scale municipal WWTP in Central Finland was aimed to explore applicability of high performance liquid chromatography – size exclusion chromatography (HPSEC) with simultaneous UV and fluorescence detection as a tool for advanced routine monitoring of wastewater treatment. High, intermediate, and low molecular weight (MW) fractions of untreated wastewater (influent) and treated wastewater (secondary effluent) were characterized in terms of UV absorbance at 254 nm (UVA254) and specific fluorescence representing tyrosine-like, tryptophan-like, and humic/fulvic-like compounds. The activated sludge treatment removed 97 ± 1% of BOD, 93 ± 2% of COD, 71 ± 7% of D…

size-exclusion chromatographywastewater treatmentwastewater characterizationfluoresenssiUV absorptionmolecular weight distributionjätevesijäteveden käsittely
researchProduct

Cognition, metacognition and the patient perspective : new ways to evaluate and rehabilitate schizophrenia patients in forensic psychiatric care

2016

This research focused on factors associated with schizophrenia as well as on the feasibility and effectiveness of group metacognitive training (MCT) in schizophrenia patients with a history of violence in a high-security forensic hospital setting. One of the aims was to scrutinize reasoning ability in regards to jumping to conclusions (JTC) cognitive bias and the expression of cognitive insight (insight into one’s own thinking), a metacognitive ability. A second aim was to examine the associations of these factors with each other and with insight into illness and delusions. Moreover, the patients’ health-related quality of life (HRQOL) was explored. A further objective was to study the pote…

skitsofreniatreatmentpsykiatriset potilaatelämänlaatumetacognitive trainingpatient perspectiveforensic psychiatrycognitive insightpotilaslähtöisyysschizophreniaquality of lifemetakognitioryhmäterapiaoikeuspsykiatriapsykiatrinen kuntoutusclinical insightväkivaltaisuusjumping to conclusions
researchProduct

Cognitive behavioural therapy interventions for insomnia among shift workers: RCT in an occupational health setting

2019

Abstract Introduction The aim of the study was to compare the effectiveness of cognitive behavioural therapy interventions for insomnia (CBT-I) to that of a sleep hygiene intervention in a randomized controlled design among shift workers. We also studied whether the features of shift work disorder (SWD) affected the results. Methods A total of 83 shift workers with insomnia disorder were partially randomized into a group-based CBT-I, self-help CBT-I, or sleep hygiene control intervention. The outcomes were assessed before and after the interventions and at 6-month follow-up using questionnaires, a sleep diary, and actigraphy. Results Perceived severity of insomnia, sleep-related dysfunction…

sleep hygiene educationMaleShift work disorderShift workinsomniaPsychological interventionunettomuusSelf-helpShift work0302 clinical medicineSleep hygiene educationSleep Initiation and Maintenance DisordersInsomniaOccupational health services030212 general & internal medicineself-helpBurnout ProfessionalFinlandSleep disorderSleep hygienecognitive behavioural therapy for insomniaMiddle AgedCognitive behavioural therapy for insomniaSLEEP DISORDER3142 Public health care science environmental and occupational healthPREVALENCE3. Good healthTreatment OutcomevuorotyöPsychotherapy Groupkognitiivinen käyttäytymisterapiaFemaleOriginal ArticleSleep diarymedicine.symptomshift work disorderSEVERITY INDEXAdultmedicine.medical_specialtyInsomniaVALIDATION03 medical and health sciencesSleep Disorders Circadian Rhythmmental disordersmedicineHumansSleep Hygieneoccupational health servicesunihäiriötCognitive Behavioral Therapytyöterveysbusiness.industryPublic Health Environmental and Occupational HealthCorrectionActigraphymedicine.diseaseActigraphyitseapu (psykologia)shift workMoodPhysical therapyNURSESbusiness030217 neurology & neurosurgeryInternational Archives of Occupational and Environmental Health
researchProduct

Excessive Daytime Sleepiness in Obstructive Sleep Apnea Patients Treated With Continuous Positive Airway Pressure: Data From the European Sleep Apnea…

2021

Excessive daytime sleepiness (EDS) is a symptom of obstructive sleep apnea (OSA) that resolves under treatment with continuous positive airway pressure (CPAP). In some patients, sleepiness persists despite CPAP treatment. We retrospectively analyzed data on subjective residual EDS, assessed as an Epworth Sleepiness Scale score (ESS) >10, in patients from the European Sleep Apnea Database (n = 4,853, mean age +/- SD 54.8 +/- 11.8 years, 26.1% females), at baseline and at the first visit (median follow-up: 5 months, interquartile range 3-13). An ESS > 10 occurred in 56% of patients at baseline and in 28.2% of patients at follow-up. Residual EDS was analyzed in 2,190 patients (age: 55.1 +/- 12…

sleep latencyResidual Sleepinessmedicine.medical_treatment[SDV]Life Sciences [q-bio]Excessive daytime sleepinessSettore MED/10 - Malattie Dell'Apparato Respiratoriocomputer.software_genreCpap adherence03 medical and health sciences0302 clinical medicineInterquartile rangeCpap Usemedicinefollow-upContinuous positive airway pressureObesityRC346-429ComputingMilieux_MISCELLANEOUSresidual sleepnessOriginal ResearchWake-Active NeuronsDatabasebusiness.industryresidual sleepineEpworth Sleepiness ScaleSleep apneaEpworth sleepness ScaleEpworth Sleepiness Scalemedicine.diseaseCPAP adherenceImportant Differencenervous system diseasesrespiratory tract diseasesScaleObstructive sleep apneaLifestyle factors030228 respiratory systemNeurologysleep durationHuman medicineNeurology. Diseases of the nervous systemNeurology (clinical)medicine.symptombusinesscomputer030217 neurology & neurosurgery
researchProduct

Virtual Reality, Augmented Reality, and In Vivo Exposure Therapy: A Preliminary Comparison of Treatment Efficacy in Small Animal Phobia

2018

This study aggregated data from three randomized control trials to explore the differential efficacy of three forms of exposure therapy, namely, in vivo (iVET), virtual reality (VRET), and augmented reality (ARET), in the treatment of small animal phobia. Additionally, baseline patient characteristics were used to detect subgroups of patients who showed a differential response to certain treatment modalities. Primary measures were distance covered, anxiety during the behavioral avoidance test (BAT), and overall fear of small animals. A repeated-measures analysis of variance was used to explore the overall treatment effect across the exposure modalities. A cluster analysis and an analysis of…

small animal phobiamedicine.medical_specialtySocial Psychologyin vivo exposure therapymedicine.medical_treatmentExposure therapyVirtual realityAnxietylaw.inventionVirtual Reality Exposure Therapyaugmented reality exposure therapyPhysical medicine and rehabilitationRandomized controlled trialIn vivolawSmall animalMedicineAnimalsCluster AnalysisHumansApplied PsychologyRandomized Controlled Trials as Topicbusiness.industryCommunicationVirtual Reality Exposure Therapyvirtual reality exposure therapyGeneral MedicineOriginal ArticlesFearTreatment efficacyComputer Science ApplicationsHuman-Computer InteractionPhobic DisordersAugmented realitybusiness
researchProduct